SANA logo

Sana Biotechnology, Inc. (SANA) EBITDA

annual EBITDA:

-$255.98M+$38.96M(+13.21%)
December 31, 2024

Summary

  • As of today (September 17, 2025), SANA annual EBITDA is -$255.98 million, with the most recent change of +$38.96 million (+13.21%) on December 31, 2024.
  • During the last 3 years, SANA annual EBITDA has fallen by -$27.30 million (-11.94%).
  • SANA annual EBITDA is now -3014.10% below its all-time high of -$8.22 million, reached on December 31, 2018.

Performance

SANA EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSANAincome statement metrics

quarterly EBITDA:

-$41.21M+$3.91M(+8.67%)
June 30, 2025

Summary

  • As of today (September 17, 2025), SANA quarterly EBITDA is -$41.21 million, with the most recent change of +$3.91 million (+8.67%) on June 30, 2025.
  • Over the past year, SANA quarterly EBITDA has increased by +$7.64 million (+15.64%).
  • SANA quarterly EBITDA is now -19.93% below its all-time high of -$34.36 million, reached on December 31, 2019.

Performance

SANA quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSANAincome statement metrics

TTM EBITDA:

-$191.85M+$7.64M(+3.83%)
June 30, 2025

Summary

  • As of today (September 17, 2025), SANA TTM EBITDA is -$191.85 million, with the most recent change of +$7.64 million (+3.83%) on June 30, 2025.
  • Over the past year, SANA TTM EBITDA has increased by +$84.17 million (+30.49%).
  • SANA TTM EBITDA is now -458.38% below its all-time high of -$34.36 million, reached on December 31, 2019.

Performance

SANA TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSANAincome statement metrics

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

SANA EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+13.2%+15.6%+30.5%
3 y3 years-11.9%+52.6%+33.1%
5 y5 years-168.1%+1.8%-357.4%

SANA EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-11.9%+13.2%at high+59.4%at high+38.6%
5 y5-year-168.1%+13.2%-19.9%+59.4%-458.4%+38.6%
alltimeall time-3014.1%+13.2%-19.9%+59.4%-458.4%+38.6%

SANA EBITDA History

DateAnnualQuarterlyTTM
Jun 2025
-
-$41.21M(-8.7%)
-$191.85M(-3.8%)
Mar 2025
-
-$45.12M(-6.1%)
-$199.49M(-22.1%)
Dec 2024
-$255.98M(-13.2%)
-$48.06M(-16.4%)
-$255.97M(-7.7%)
Sep 2024
-
-$57.47M(+17.7%)
-$277.23M(+0.4%)
Jun 2024
-
-$48.85M(-51.9%)
-$276.02M(-10.5%)
Mar 2024
-
-$101.59M(+46.5%)
-$308.53M(+9.1%)
Dec 2023
-$294.94M(+22.2%)
-$69.33M(+23.2%)
-$282.77M(+1.6%)
Sep 2023
-
-$56.26M(-30.8%)
-$278.27M(-9.3%)
Jun 2023
-
-$81.35M(+7.3%)
-$306.87M(-1.8%)
Mar 2023
-
-$75.84M(+17.0%)
-$312.39M(+0.4%)
DateAnnualQuarterlyTTM
Dec 2022
-$241.32M(+5.5%)
-$64.83M(-23.6%)
-$311.21M(+0.5%)
Sep 2022
-
-$84.86M(-2.3%)
-$309.55M(+8.0%)
Jun 2022
-
-$86.87M(+16.3%)
-$286.73M(+13.2%)
Mar 2022
-
-$74.66M(+18.2%)
-$253.29M(+12.0%)
Dec 2021
-$228.68M(+51.5%)
-$63.16M(+1.8%)
-$226.09M(+10.4%)
Sep 2021
-
-$62.04M(+16.1%)
-$204.87M(+43.4%)
Jun 2021
-
-$53.43M(+12.6%)
-$142.83M(+59.8%)
Mar 2021
-
-$47.46M(+13.2%)
-$89.41M(+113.2%)
Dec 2020
-$150.95M(+58.1%)
-$41.94M(+22.1%)
-$41.94M(+22.1%)
Dec 2019
-$95.50M(+1061.8%)
-$34.36M
-$34.36M
Dec 2018
-$8.22M
-
-

FAQ

  • What is Sana Biotechnology, Inc. annual EBITDA?
  • What is the all time high annual EBITDA for Sana Biotechnology, Inc.?
  • What is Sana Biotechnology, Inc. annual EBITDA year-on-year change?
  • What is Sana Biotechnology, Inc. quarterly EBITDA?
  • What is the all time high quarterly EBITDA for Sana Biotechnology, Inc.?
  • What is Sana Biotechnology, Inc. quarterly EBITDA year-on-year change?
  • What is Sana Biotechnology, Inc. TTM EBITDA?
  • What is the all time high TTM EBITDA for Sana Biotechnology, Inc.?
  • What is Sana Biotechnology, Inc. TTM EBITDA year-on-year change?

What is Sana Biotechnology, Inc. annual EBITDA?

The current annual EBITDA of SANA is -$255.98M

What is the all time high annual EBITDA for Sana Biotechnology, Inc.?

Sana Biotechnology, Inc. all-time high annual EBITDA is -$8.22M

What is Sana Biotechnology, Inc. annual EBITDA year-on-year change?

Over the past year, SANA annual EBITDA has changed by +$38.96M (+13.21%)

What is Sana Biotechnology, Inc. quarterly EBITDA?

The current quarterly EBITDA of SANA is -$41.21M

What is the all time high quarterly EBITDA for Sana Biotechnology, Inc.?

Sana Biotechnology, Inc. all-time high quarterly EBITDA is -$34.36M

What is Sana Biotechnology, Inc. quarterly EBITDA year-on-year change?

Over the past year, SANA quarterly EBITDA has changed by +$7.64M (+15.64%)

What is Sana Biotechnology, Inc. TTM EBITDA?

The current TTM EBITDA of SANA is -$191.85M

What is the all time high TTM EBITDA for Sana Biotechnology, Inc.?

Sana Biotechnology, Inc. all-time high TTM EBITDA is -$34.36M

What is Sana Biotechnology, Inc. TTM EBITDA year-on-year change?

Over the past year, SANA TTM EBITDA has changed by +$84.17M (+30.49%)
On this page